ConductScience.org, home

Paper41864914

Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial.

Chu S and 5 others. BMC Med, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial. Papers, record 41864914. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41864914

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial.
PubMed
Journal
BMC Med
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-12
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chu SShuilian
2Zhang DDi
3Li JJiachen
4Feng LLin
5Tong ZZhaohui
6Liang LLirong

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Smoking CessationMajor topic
Social MediaMajor topic
HotlinesMajor topic
Humans
Adult
Female
China
Male
Middle Aged
Treatment Outcome
Counseling

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CFH 2024-1G-1062Capital's Funds for Health Improvement and ResearchPubMed
ysbz2022002Financial Budgeting Project of Beijing Institute of Respiratory MedicinePubMed

Source PubMed

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127207211Text Messaging-Based Interventions for Smoking Cessation: A Systematic Review and Meta-Analysis.JMIR Mhealth Uhealth2016https://conductscience.org/library/papers/27207211PubMed
234472676Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial.Addiction2022https://conductscience.org/library/papers/34472676PubMed
332195370A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker.NPJ Digit Med2020https://conductscience.org/library/papers/32195370PubMed
434051921Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990-2019.Lancet Public Health2021https://conductscience.org/library/papers/34051921PubMed
536964513Evaluation of an innovative mHealth-based integrated modality for smoking cessation in Chinese smokers: protocol for a randomized controlled trial.BMC Public Health2023https://conductscience.org/library/papers/36964513PubMed
633095184Mobile Social Network-Based Smoking Cessation Intervention for Chinese Male Smokers: Pilot Randomized Controlled Trial.JMIR Mhealth Uhealth2020https://conductscience.org/library/papers/33095184PubMed
719246437The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status.Nicotine Tob Res2009https://conductscience.org/library/papers/19246437PubMed
837251625Efficacy of WeChat-based online smoking cessation intervention ('WeChat WeQuit') in China: a randomised controlled trial.EClinicalMedicine2023https://conductscience.org/library/papers/37251625PubMed
937405266Effectiveness and Acceptability of a Comprehensive Mobile Health-Based Modality for Smoking Cessation - Beijing Municipality, China, 2022.China CDC Wkly2023https://conductscience.org/library/papers/37405266PubMed
1033927586Mobile chat-based support plus nicotine replacement therapy sampling to promote smoking cessation for community smokers: A randomized controlled trial.Tob Induc Dis2021https://conductscience.org/library/papers/33927586PubMed
1136130170Facebook Intervention to Connect Alaska Native People With Resources and Support to Quit Smoking: CAN Quit Pilot Randomized Controlled Trial.Nicotine Tob Res2023https://conductscience.org/library/papers/36130170PubMed
1236857056Assessment of a Text Message-Based Smoking Cessation Intervention for Adult Smokers in China: A Randomized Clinical Trial.JAMA Netw Open2023https://conductscience.org/library/papers/36857056PubMed
1329797621A randomized controlled evaluation of the tobacco status project, a Facebook intervention for young adults.Addiction2018https://conductscience.org/library/papers/29797621PubMed
1416567055The psychometric properties of the Chinese version of the Fagerstrom Test for Nicotine Dependence.Addict Behav2006https://conductscience.org/library/papers/16567055PubMed
1537625030Effective Behavior Change Techniques in Digital Health Interventions for the Prevention or Management of Noncommunicable Diseases: An Umbrella Review.Ann Behav Med2023https://conductscience.org/library/papers/37625030PubMed
1640621203Smoking Prevalence in Urban and Rural Areas - China, 2024.China CDC Wkly2025https://conductscience.org/library/papers/40621203PubMed
1738855571Comparative Effectiveness of Mobile Health-Based Comprehensive Smoking Cessation Modalities and Traditional Clinic-Delivered Treatments - Beijing Municipality, China, May 2022 to April 2024.China CDC Wkly2024https://conductscience.org/library/papers/38855571PubMed
1826928205Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention.Tob Control2017https://conductscience.org/library/papers/26928205PubMed
1925006045Intermediate cessation outcomes among quitline callers during a national tobacco education campaign.Nicotine Tob Res2014https://conductscience.org/library/papers/25006045PubMed
2028239919Large multi-centre pilot randomized controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit).Addiction2017https://conductscience.org/library/papers/28239919PubMed

See all 50 referencesDownload CSV of references

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
ChiCTRChiCTR2200066427

Source PubMed

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41864914

GET https://conductscience.org/api/papers/v1/41864914/references?page=2